Articles tagged "Infection"

2021 American Transplant Congress
T-Cell Exhaustion in EBV DNAemic Solid Organ Transplant Recipients
S. Kothari, T. Ku, D. Kumar, A. Humar, V. H. Ferreira
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada
*Purpose: In transplant recipients, disease severity after infection with Epstein-Barr virus (EBV) may range from asymptomatic DNAemia to PTLD. Host factors likely play a key…
2021 American Transplant Congress
Outcomes in High Risk CMV Liver Transplants with Elevated MELD Scores
S. Freedman¹, K. Saunders², T. Sparkes¹, B. Masters¹, M. Plazak¹, K. Saharia³, D. Maluf³, B. Ravichandran²
¹University of Maryland Medical Center, Baltimore, MD, ²University of Maryland School of Pharmacy, Baltimore, MD, ³University of Maryland School of Medicine, Baltimore, MD
*Purpose: There is inconclusive evidence on the impact of MELD score on CMV viremia after liver transplantation. Following the implementation of Share 35, liver transplant…
2021 American Transplant Congress
Current Practices for Management and Treatment of COVID-19 in Immunocompromised Adults: A Survey of Institutions
H. H. Nam¹, S. Aslam², O. Beaird³, G. Forrest⁴, M. Fung⁵, A. Limaye⁶, A. Multani³, J. Nelson⁷, R. Rakita⁶, L. Strasfeld⁸, J. Schaenman³
¹Medicine, University of California - Irvine, Orange, CA, ²Division of Infectious Diseases and Global Public Health, University of California - San Diego, San Diego, CA, ³Medicine, University of California - Los Angeles, Los Angeles, CA, ⁴Medicine, Rush University, Chicago, IL, ⁵Medicine, University of California - San Francisco, San Francisco, CA, ⁶Medicine, University of Washington, Seattle, WA, ⁷Medicine, Stanford University, Palo Alto, CA, ⁸Medicine, Oregon Health and Science University, Portland, OR
*Purpose: The optimal testing strategy for solid organ transplantation (SOT) donor and recipient evaluation, as well as treatment for COVID-19 is unknown. We assessed the…
2021 American Transplant Congress
Relationship Between Diabetes Mellitus and Covid-19 Prognosis in Kidney Transplant Patients
D. D. de Lucena, I. A. de Brito, M. P. Cristelli, J. O. Medina-Pestana, H. Tedesco-Silva, É. B. Rangel
Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil
*Purpose: A high number of comorbidities associated with the severity of the disease caused by SARS-CoV-2 (COVID-19) has been reported, such as systemic arterial hypertension…
2021 American Transplant Congress
Impact of Cytomegalovirus Prophylaxis on Herpes Simplex and Varicella Zoster Virus Infections in Kidney Transplant Recipients
K. Ridgely¹, B. Crowther², P. Klem², K. Schoeppler¹, K. Schwarz¹, A. Nadrash², V. Lewis¹, E. Benamu³
¹Department of Pharmacy Services, UCHealth University of Colorado Hospital, Aurora, CO, ²Ambulatory Care Pharmacy Services, UCHealth University of Colorado Hospital, Aurora, CO, ³Department of Medicine, UCHealth University of Colorado Hospital, Aurora, CO
*Purpose: To assess the impact of cytomegalovirus (CMV) targeted antiviral prophylaxis on the development of herpes simplex (HSV) and varicella zoster (VZV) infections after kidney…
2021 American Transplant Congress
Changes in Liver Transplant Volume and Induction During the Covid-19 Era
T. Alhamad, J. Wellen, K. Lentine, M. Doyke, W. Chapman, Y. Al-Hosni, D. Axelrod, S. Chang
Washington University School of Medicine in St. Louis, Saint Louis, MO
*Purpose: The rapid spread and high infectivity of COVID-19 resulted in disruption of transplant procedures at many centers, including pauses in living donor transplantation and…
2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…
2021 American Transplant Congress
Covid-19 Related Deaths Across the U.S. in Kidney Transplant Recipients
K. Goli, N. T. Galvan, R. Cotton, J. A. Goss, C. A. O'Mahony, A. Rana
Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: The COVID-19 pandemic poses a unique challenge for immunosuppression patients following kidney transplantation. Studies involving a single center or few centers have suggested that…
2021 American Transplant Congress
Does the NSQIP-Transplant Experience Demonstrate That Obese Kidney Transplant Recipients are Still at Increased Risk for Surgical Site Infections?
H. C. Yaffe¹, A. K. Belli¹, J. R. Parekh², D. L. Sudan³, N. Elias⁴, K. D. Conzen⁵, D. P. Foley⁶, R. Hirose⁷, S. M. Greenstein¹
¹Surgery, Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, ²Surgery, University of California San Diego, San Diego, CA, ³Surgery, Division of Abdominal Transplant Surgery, Duke University Medical Center, Durham, NC, ⁴Surgery, Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, ⁵Surgery, Division of Transplant Surgery, University of Colorado Hospital, Aurora, CO, ⁶Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁷Surgery, University of California San Francisco, San Francisco, CA
*Purpose: The National Surgical Quality Improvement Program for Transplant (NSQIP-T) was designed to track surgical outcomes in adult liver and kidney transplants (KTX). The Pilot…
2021 American Transplant Congress
Covid Studies in 208 Patients with Consent for Donation
A. L. Friedman, C. Ezzell, K. Delli Carpini
LiveOnNY, New York, NY
*Purpose: To prevent transmission of SARS CoV 2 via solid organ donation from deceased donors.*Methods: Comprehensive medical and psychosocial evaluation of potential deceased organ donors…